Necroptosis in cancer: insight from epigenetic, post-transcriptional and post-translational modifications

Jinxin Tang1,2,3,4, Yan Zhuang1,4, Yibo Zhang1,4

  • 1Department of Orthopaedics, The Second Xiangya Hospital of Central South University, Changsha, 410011, China.

Insights

This review explores how epigenetic, post-transcriptional, and post-translational modifications regulate necroptosis (programmed cell death) in cancer. Understanding these mechanisms offers new therapeutic targets for cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Necroptosis is a programmed cell death pathway with anti-cancer immune potential.
  • Regulating necroptosis for cancer therapy is challenging.
  • Epigenetic, post-transcriptional, and post-translational modifications influence cancer but their role in necroptosis is unclear.

Purpose of the Study:

  • To systematically review the role of epigenetic, post-transcriptional, and post-translational modifications in regulating necroptosis in cancer.
  • To identify potential regulatory targets within these modification pathways.
  • To discuss the therapeutic implications for cancer treatment.

Main Methods:

  • Literature review focusing on molecular modifications and necroptosis in cancer.
  • Analysis of mechanisms linking epigenetic, post-transcriptional, and post-translational modifications to necroptosis.
  • Identification of key regulatory nodes and therapeutic targets.

Main Results:

  • These modifications significantly impact cancer progression and necroptosis.
  • Specific pathways and targets involved in regulating necroptosis have been identified.
  • The interplay between these modifications and necroptosis offers promising therapeutic avenues.

Conclusions:

  • Epigenetic, post-transcriptional, and post-translational modifications are critical regulators of necroptosis in cancer.
  • Targeting these modifications presents a novel strategy for cancer therapy.
  • Further research into these mechanisms will support necroptosis-based cancer treatments.

Related Concept Videos

Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.8K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.1K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
12.0K
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
7.8K
Histone Modification02:32

Histone Modification

3.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K